Atlas Trials

Pharmacokinetic Properties of Various Modified Release Tablet Formulations of Lu AF11167

Clinical trial NCT02260830 · COMPLETED

Trial details

NCT number
NCT02260830
Sponsor
H. Lundbeck A/S
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Schizophrenia
Start date
2014-08-01
Primary completion
2015-03-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.